Jack Scannell is a consultant, researcher, and entrepreneur. Jack is one of the world’s leading authorities on pharmaceutical R&D productivity. He co-authored the influential 2012 paper in Nature Reviews Drug Discovery that introduced “Eroom’s Law,” a concept highlighting how drug discovery has become slower and more expensive over time—essentially the opposite of Moore’s Law. Scannell has advised major pharmaceutical firms and is a noted commentator on strategies to improve innovation efficiency in the life sciences. He is currently building <a target="_blank" href="https://etherospharma.com/">Ethereos</a>.Explore Infinita City:* <a target="_blank" href="https://www.infinita.city/times">Explore the Archive: The Infinita City Times</a>* <a target="_blank" href="https://www.infinita.city">Visit Infinita City</a>* <a target="_blank" href="https://www.infinita.city/builders-hub">Join the Builders’ Hub on Telegram</a>* <a target="_blank" href="https://x.com/InfinitaCity">Follow Infinita City on X</a> This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.infinitacitytimes.com?utm_medium=podcast&#38;utm_campaign=CTA_1">www.infinitacitytimes.com</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Ep. 92: Jack Scannell On Eroom’s Law In Drug Development

Stranded Technologies Podcast

AI Chapters

AI Insights

Reviews